Hopital Huriez, CHRU de Lille
Lille 59037 Cedex
1 studies enrolling now · 10 studies all time
What they study most
Carcinoma, Basal Cell, Crohn's Disease, Ulcerative Colitis
Studies at this site
- A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — Recruiting now
- PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy — Completed
- B0151005 Open-Label Extension Study — Completed
- A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis — Completed
- A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
- Long-Term Safety Of PF-00547659 In Ulcerative Colitis — Completed
- A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease — Completed
- A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease — Completed
- The Safety And Efficacy Of Maintenance Therapy With CP-690,550 — Completed
- A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy — Completed